Español
Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Find News Releases

Search For:
Between these dates:
NCI Cancer Center News

UNC-developed kinase test may yield gains for drug-resistant cancers

  • Posted: April 13, 2012

In a paper published in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases “en masse,” enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies. Kinases are proteins expressed in human tissues that play a key role in cell growth, particularly in cancer.  Of the 518 known human kinases, about 400 are expressed in cancers, but which ones and how many are actually active in tumors has been difficult to measure.

Click here to read full press release.

###

NCI comprehensive cancer center logoAmong the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.



This text may be reproduced or reused freely. Please credit the National Cancer Institute as the source. Any graphics may be owned by the artist or publisher who created them, and permission may be needed for their reuse.